Statins after acute coronary syndrome: A missed opportunity

Heart

Volumn 100, Issue 10, 2014, Pages 752-753

  Roth, Gregory A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; DRUG EFFICACY; EDITORIAL; ETHNICITY; GENDER; HEALTH CARE DELIVERY; HUMAN; MEDICAL RECORD REVIEW; MEDICATION THERAPY MANAGEMENT; PATIENT COMPLIANCE; PATIENT DECISION MAKING; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT REFUSAL;

ACUTE CORONARY SYNDROME; FEMALE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE;

EID: 84899633115     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-305480     Document Type: Editorial

References (10)

1. Smith SC, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011;124:2458-73.
2. Grey C, Jackson R, Wells S, et al. Maintenance of statin use over three years following acute coronary syndromes: a national data linkage study (ANZACS-QI-2). Heart 2014;100:770-4.
3. WHO MONICA Project Principal Investigators. The world health organization monica project (monitoring trends and determinants in cardiovascular disease): A major international collaboration. J Clin Epidemiol 1988;41:105-14.
4. Ellerbeck EF,Jencks SF,Radford MJ,et al. Quality of care for medicare patients with acute myocardial infarction: A four-state pilot study from the cooperative cardiovascular project. JAMA 1995;273:1509-14.
5. Roth GA, Morden NE, Zhou W, et al. Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stent. Circ Cardiovasc Qual Outcomes 2012;5:103-12.
6. De Lemos JA, Blazing MA, Wiviott SD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase z of the a to z trial. JAMA 2004;292:1307-16. (Pubitemid 39223221)
7. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. N Engl J Med 2004;350:1495-504. (Pubitemid 38477774)
8. Choudhry NK, Avorn J, Glynn RJ, et al. Full Coverage for Preventive Medications after Myocardial Infarction. N Engl J Med 2011;365:2088-97.
9. Baigent C, Blackwell L, Emberson J; Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet 2010;376:1670-81.
10. Wang L, Porter B, Maynard C, et al. Predicting risk of hospitalization or death among patients receiving primary care in the Veterans Health Administration. Med Care 2013;51:368-73.